Gilead Sciences Inc (GILD)
66.16
-0.77
(-1.15%)
USD |
NASDAQ |
Apr 18, 16:00
66.49
+0.33
(+0.50%)
After-Hours: 20:00
Gilead Sciences Price: 66.16 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 67.01 | 67.02 | 65.90 | 66.16 | 6.382M |
| Apr 17, 2024 | 67.35 | 67.55 | 66.89 | 66.93 | 5.288M |
| Apr 16, 2024 | 67.80 | 67.89 | 67.18 | 67.31 | 4.975M |
| Apr 15, 2024 | 68.27 | 68.46 | 67.70 | 67.75 | 7.718M |
| Apr 12, 2024 | 68.52 | 68.62 | 67.62 | 68.07 | 5.692M |
| Apr 11, 2024 | 68.46 | 69.02 | 68.30 | 68.65 | 6.072M |
| Apr 10, 2024 | 69.76 | 69.76 | 68.06 | 68.12 | 7.983M |
| Apr 09, 2024 | 69.16 | 69.95 | 69.11 | 69.94 | 5.928M |
| Apr 08, 2024 | 69.05 | 69.55 | 69.05 | 69.42 | 4.589M |
| Apr 05, 2024 | 69.69 | 70.01 | 68.54 | 69.58 | 6.600M |
| Apr 04, 2024 | 71.24 | 71.39 | 69.40 | 69.55 | 7.341M |
| Apr 03, 2024 | 72.00 | 72.17 | 70.70 | 70.89 | 5.145M |
| Apr 02, 2024 | 72.82 | 72.85 | 71.90 | 72.09 | 6.139M |
| Apr 01, 2024 | 73.22 | 73.22 | 72.38 | 72.88 | 3.796M |
| Mar 28, 2024 | 73.25 | 73.87 | 73.20 | 73.25 | 8.370M |
| Mar 27, 2024 | 72.92 | 73.06 | 72.55 | 73.01 | 7.748M |
| Mar 26, 2024 | 72.32 | 72.66 | 72.11 | 72.41 | 5.363M |
| Mar 25, 2024 | 72.50 | 72.84 | 72.20 | 72.58 | 5.544M |
| Mar 22, 2024 | 73.11 | 73.23 | 72.56 | 72.61 | 7.731M |
| Mar 21, 2024 | 73.90 | 74.28 | 73.03 | 73.09 | 5.837M |
| Mar 20, 2024 | 73.27 | 73.98 | 72.80 | 73.98 | 7.311M |
| Mar 19, 2024 | 73.34 | 73.77 | 73.19 | 73.41 | 8.662M |
| Mar 18, 2024 | 73.69 | 74.17 | 73.20 | 73.26 | 6.940M |
| Mar 15, 2024 | 74.25 | 74.66 | 73.29 | 73.69 | 13.96M |
| Mar 14, 2024 | 74.72 | 75.02 | 73.82 | 74.21 | 8.399M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
56.65
Minimum
Dec 30 2020
89.47
Maximum
Dec 08 2022
70.23
Average
68.10
Median
Price Benchmarks
| Amgen Inc | 262.75 |
| Johnson & Johnson | 145.74 |
| Eli Lilly and Co | 745.95 |
| CymaBay Therapeutics Inc (DELISTED) | 32.48 |
| Arcus Biosciences Inc | 14.84 |
Price Related Metrics
| PE Ratio | 14.70 |
| PS Ratio | 3.068 |
| PEG Ratio | 0.6312 |
| Price to Book Value | 3.609 |
| Price to Free Cash Flow | 11.21 |
| Earnings Yield | 6.80% |
| Market Cap | 82.42B |
| PEGY Ratio | 0.5287 |
| Operating PE Ratio | 9.446 |
| Normalized PE Ratio | 12.60 |